+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Forkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathy



Forkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathy



Cardiovascular Diabetology 15: 44



Diabetic cardiomyopathy (DCM) is a disorder of the heart muscle in people with diabetes that can occur independent of hypertension or vascular disease. The underlying mechanism of DCM is incompletely understood. Some transcription factors have been suggested to regulate the gene program intricate in the pathogenesis of diabetes prompted cardiac injury. Forkhead box transcription factor 1 is a pleiotropic transcription factor that plays a pivotal role in a variety of physiological processes. Altered FOXO1 expression and function have been associated with cardiovascular diseases, and the important role of FOXO1 in DCM has begun to attract attention. In this review, we focus on the FOXO1 pathway and its role in various processes that have been related to DCM, such as metabolism, oxidative stress, endothelial dysfunction, inflammation and apoptosis.

(PDF emailed within 0-6 h: $19.90)

Accession: 057893755

Download citation: RISBibTeXText

PMID: 26956801

DOI: 10.1186/s12933-016-0361-1


Related references

Hypertrophic cardiomyopathy in high-fat diet-induced obesity: role of suppression of forkhead transcription factor and atrophy gene transcription. American Journal of Physiology. Heart and Circulatory Physiology 295(3): H1206-H1215, 2008

Forkhead-associated domains of the tobacco NtFHA1 transcription activator and the yeast Fhl1 forkhead transcription factor are functionally conserved. Journal of Biological Chemistry 277(41): 38781-38790, 2002

Role of Sp1 transcription factor in the pathogenesis of diabetic retinopathy. 2012

FOXP1 forkhead transcription factor is associated with the pathogenesis of endometrial cancer. Heliyon 2(5): E00116, 2016

The evolutionary rewiring of the ribosomal protein transcription pathway modifies the interaction of transcription factor heteromer Ifh1-Fhl1 (interacts with forkhead 1-forkhead-like 1) with the DNA-binding specificity element. Journal of Biological Chemistry 288(24): 17508-17519, 2013

A novel role for the forkhead transcription factor FOXL2 in activin A-regulated follicle-stimulating hormone beta subunit transcription. Molecular Endocrinology 23(7): 1001-1013, 2009

Oxidative stress stimulates testicular orphan receptor 4 through forkhead transcription factor forkhead box O3a. Endocrinology 149(7): 3490-3499, 2008

Forkhead class O transcription factor 3a activation and Sirtuin1 overexpression in the hypertrophied myocardium of the diabetic Goto-Kakizaki rat. Journal of Hypertension 26(2): 334-344, 2008

Colonic PDGFRα Overexpression Accompanied Forkhead Transcription Factor FOXO3 Up-Regulation in STZ-Induced Diabetic Mice. Cellular Physiology and Biochemistry 43(1): 158-171, 2017

The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma. Endocrinology 149(4): 1942-1950, 2007

Modulation of AT-1R/AMPK-MAPK cascade plays crucial role for the pathogenesis of diabetic cardiomyopathy in transgenic type 2 diabetic (Spontaneous Diabetic Torii) rats. Biochemical Pharmacology 83(5): 653-660, 2012

The role of forkhead box Q1 transcription factor in ovarian epithelial carcinomas. International Journal of Molecular Sciences 13(11): 13881-13893, 2012

Novel role of forkhead box O 4 transcription factor in cancer: Bringing out the good or the bad. Seminars in Cancer Biology 50: 1-12, 2018

Role of Forkhead Box O (FOXO) transcription factor in aging and diseases. Gene 648: 97-105, 2018

Metoprolol increases the expression of beta(3)-adrenoceptors in the diabetic heart: effects on nitric oxide signaling and forkhead transcription factor-3. European Journal of Pharmacology 595(1-3): 44-51, 2008